Bombay Dyeing & Manufacturing Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 5, 2025, 2:26 pm

Quick Insight

Bombay Dyeing & Manufacturing Company Ltd is currently trading at ₹182, with a market capitalization of ₹3,757 crore, reflecting a high P/E ratio of 131, indicating investor optimism despite the company's modest ROE of 1.37% and ROCE of 2.60%. The negative operating profit margin of -4% raises concerns about operational efficiency, especially with an interest coverage ratio (ICR) of 0.18x, suggesting potential difficulties in meeting debt obligations. With promoter ownership at 53.59% and a shareholder base of 147,960, the company shows a strong insider commitment. However, the significant reserves of ₹2,302 crore compared to negligible borrowings of ₹3 crore could provide a cushion for future growth. Investors should approach with caution, as the high valuation metrics may not be justified by current performance.

Competitors of Bombay Dyeing & Manufacturing Company Ltd

All Competitor Stocks of Bombay Dyeing & Manufacturing Company Ltd

Quarterly Result

Last Updated: May 31, 2025, 9:36 am

Below is a detailed analysis of the quarterly data for Bombay Dyeing & Manufacturing Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 359.00 Cr.. The value appears to be declining and may need further review. It has decreased from 415.00 Cr. (Dec 2024) to 359.00 Cr., marking a decrease of 56.00 Cr..
• For Expenses, as of Mar 2025, the value is 372.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 399.00 Cr. (Dec 2024) to 372.00 Cr., marking a decrease of 27.00 Cr..
• For Operating Profit, as of Mar 2025, the value is -13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Dec 2024) to -13.00 Cr., marking a decrease of 29.00 Cr..
• For OPM %, as of Mar 2025, the value is -4.00%. The value appears to be declining and may need further review. It has decreased from 4.00% (Dec 2024) to -4.00%, marking a decrease of 8.00%.
• For Other Income, as of Mar 2025, the value is 36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Dec 2024) to 36.00 Cr., marking a decrease of 54.00 Cr..
• For Interest, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 3.00 Cr..
• For Depreciation, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 8.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 94.00 Cr. (Dec 2024) to 13.00 Cr., marking a decrease of 81.00 Cr..
• For Tax %, as of Mar 2025, the value is 9.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Dec 2024) to 9.00%, marking a decrease of 16.00%.
• For Net Profit, as of Mar 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 70.00 Cr. (Dec 2024) to 11.00 Cr., marking a decrease of 59.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.56. The value appears to be declining and may need further review. It has decreased from 3.39 (Dec 2024) to 0.56, marking a decrease of 2.83.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 4:03 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 3:45 pm

Below is a detailed analysis of the balance sheet data for Bombay Dyeing & Manufacturing Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 41.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 41.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,302.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,805.00 Cr. (Mar 2024) to 2,302.00 Cr., marking an increase of 497.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 647.00 Cr.. The value appears to be improving (decreasing). It has decreased from 709.00 Cr. (Mar 2024) to 647.00 Cr., marking a decrease of 62.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,993.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,558.00 Cr. (Mar 2024) to 2,993.00 Cr., marking an increase of 435.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 583.00 Cr.. The value appears strong and on an upward trend. It has increased from 575.00 Cr. (Mar 2024) to 583.00 Cr., marking an increase of 8.00 Cr..
• For CWIP, as of Mar 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2024) to 27.00 Cr., marking an increase of 13.00 Cr..
• For Investments, as of Mar 2025, the value is 1,466.00 Cr.. The value appears strong and on an upward trend. It has increased from 746.00 Cr. (Mar 2024) to 1,466.00 Cr., marking an increase of 720.00 Cr..
• For Other Assets, as of Mar 2025, the value is 918.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,224.00 Cr. (Mar 2024) to 918.00 Cr., marking a decrease of 306.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,993.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,558.00 Cr. (Mar 2024) to 2,993.00 Cr., marking an increase of 435.00 Cr..

Notably, the Reserves (2,302.00 Cr.) exceed the Borrowings (3.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Bombay Dyeing & Manufacturing Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 142.77. This value is within the healthy range. It has increased from -25.02 (Mar 23) to 142.77, marking an increase of 167.79.
• For Diluted EPS (Rs.), as of Mar 24, the value is 142.77. This value is within the healthy range. It has increased from -25.02 (Mar 23) to 142.77, marking an increase of 167.79.
• For Cash EPS (Rs.), as of Mar 24, the value is 144.26. This value is within the healthy range. It has increased from -23.41 (Mar 23) to 144.26, marking an increase of 167.67.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 89.42. It has increased from -61.64 (Mar 23) to 89.42, marking an increase of 151.06.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 89.42. It has increased from -61.64 (Mar 23) to 89.42, marking an increase of 151.06.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 81.75. It has decreased from 129.45 (Mar 23) to 81.75, marking a decrease of 47.70.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 2.99. This value is within the healthy range. It has decreased from 3.28 (Mar 23) to 2.99, marking a decrease of 0.29.
• For PBIT / Share (Rs.), as of Mar 24, the value is 1.47. This value is within the healthy range. It has decreased from 1.67 (Mar 23) to 1.47, marking a decrease of 0.20.
• For PBT / Share (Rs.), as of Mar 24, the value is 176.71. This value is within the healthy range. It has increased from -23.65 (Mar 23) to 176.71, marking an increase of 200.36.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 142.75. This value is within the healthy range. It has increased from -25.02 (Mar 23) to 142.75, marking an increase of 167.77.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 142.76. This value is within the healthy range. It has increased from -25.02 (Mar 23) to 142.76, marking an increase of 167.78.
• For PBDIT Margin (%), as of Mar 24, the value is 3.65. This value is below the healthy minimum of 10. It has increased from 2.53 (Mar 23) to 3.65, marking an increase of 1.12.
• For PBIT Margin (%), as of Mar 24, the value is 1.79. This value is below the healthy minimum of 10. It has increased from 1.28 (Mar 23) to 1.79, marking an increase of 0.51.
• For PBT Margin (%), as of Mar 24, the value is 216.16. This value is within the healthy range. It has increased from -18.27 (Mar 23) to 216.16, marking an increase of 234.43.
• For Net Profit Margin (%), as of Mar 24, the value is 174.62. This value exceeds the healthy maximum of 10. It has increased from -19.33 (Mar 23) to 174.62, marking an increase of 193.95.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 174.63. This value exceeds the healthy maximum of 20. It has increased from -19.32 (Mar 23) to 174.63, marking an increase of 193.95.
• For Return on Networth / Equity (%), as of Mar 24, the value is 157.39. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 157.39, marking an increase of 157.39.
• For Return on Capital Employeed (%), as of Mar 24, the value is 1.50. This value is below the healthy minimum of 10. It has decreased from 2.39 (Mar 23) to 1.50, marking a decrease of 0.89.
• For Return On Assets (%), as of Mar 24, the value is 115.15. This value is within the healthy range. It has increased from -17.25 (Mar 23) to 115.15, marking an increase of 132.40.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. It has increased from -2.16 (Mar 23) to 0.00, marking an increase of 2.16.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. It has increased from -2.92 (Mar 23) to 0.00, marking an increase of 2.92.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.60. It has decreased from 0.74 (Mar 23) to 0.60, marking a decrease of 0.14.
• For Current Ratio (X), as of Mar 24, the value is 2.04. This value is within the healthy range. It has increased from 1.03 (Mar 23) to 2.04, marking an increase of 1.01.
• For Quick Ratio (X), as of Mar 24, the value is 1.58. This value is within the healthy range. It has increased from 0.32 (Mar 23) to 1.58, marking an increase of 1.26.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.72. This value is below the healthy minimum of 4. It has increased from 0.88 (Mar 23) to 1.72, marking an increase of 0.84.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 0.18. This value is below the healthy minimum of 3. It has increased from 0.12 (Mar 23) to 0.18, marking an increase of 0.06.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -2.06. This value is below the healthy minimum of 3. It has decreased from 0.01 (Mar 23) to -2.06, marking a decrease of 2.07.
• For Enterprise Value (Cr.), as of Mar 24, the value is 2,785.25. It has decreased from 4,603.18 (Mar 23) to 2,785.25, marking a decrease of 1,817.93.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.65. This value is within the healthy range. It has decreased from 1.72 (Mar 23) to 1.65, marking a decrease of 0.07.
• For EV / EBITDA (X), as of Mar 24, the value is 45.13. This value exceeds the healthy maximum of 15. It has decreased from 67.98 (Mar 23) to 45.13, marking a decrease of 22.85.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.95. This value is within the healthy range. It has increased from 0.43 (Mar 23) to 1.95, marking an increase of 1.52.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Price / BV (X), as of Mar 24, the value is 1.76. This value is within the healthy range. It has increased from -0.94 (Mar 23) to 1.76, marking an increase of 2.70.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.95. This value is within the healthy range. It has increased from 0.43 (Mar 23) to 1.95, marking an increase of 1.52.
• For EarningsYield, as of Mar 24, the value is 0.89. This value is below the healthy minimum of 5. It has increased from -0.44 (Mar 23) to 0.89, marking an increase of 1.33.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness